Профилактика и лечение остеопороза у беременных


А.В. Ледина, В.Н. Прилепская

ФГБУ «Научный центр акушерсвта, гинекологии и перинатологии им. В.И. Кулакова» Минздрава России, Москва
В статье представлены данные об обмене кальция в организме человека, особенностях метаболизма некоторых макроэлементов и витаминов во время физиологической и осложненной беременности с акцентом на повышении риска развития остеопороза (ОП) при приеме гепарина, глюкокортикостероидов. Основными препаратами лечения и профилактики ОП являются препараты кальция и витамина D, рекомендуются соблюдение диеты, занятия физкультурой и спортом.

Литература



  1. Ребров В.Г., Громова О.А. Витамины, макро- и микроэлементы. М., 2008. 960 с.

  2. Lirani-Galvão AP, Lazaretti-Castro M. Physical approach for prevention and treatment of osteoporosis. Arq Bras Endocrinol Metabol 2010;54(2):171–78.

  3. Huiskes R. Effects of mechanical forces on maintenance and adaptation of form in trabecular bone. Nature 2000;405(6787):704–06.

  4. Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 2000;21(2):115-37.

  5. Matsumoto T, et al.Regulation of osteoblast differentiation by interleukin-11 via AP-1 and Smad signaling. Endocr J 2012;59(2):91–101.

  6. Rizzoli R. et al.The role of calcium and vitamin D in the management of osteoporosis. Bone. 2008;42(2):246–49.

  7. Martin RM, Correa PH. Bone quality and osteoporosis therapy. Arq Bras Endocrinol Metabol 2010;54(2):186–99.

  8. Щеплягина Л.А., Моисеева Т.Ю. Кальций и кость: профилактика и коррекция нарушений минерализации костной ткани // Сonsilium Medicum 2003. Т. 5. № 6. C. 29–31.

  9. Hwang SY, Putney JW Jr. Calcium signaling in osteoclasts. Biochim Biophys Acta 2011;1813(5):979–83.

  10. Nieves JW. Osteoporosis: the role of micronutrients. Am J Clin Nutr 2005;81(5): 1232–39.

  11. Prentice A. Micronutrients and the bone mineral content of the mother, fetus and newborn. J Nutr 2003;133:1693–99.

  12. Cranney A. et al. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep) 2007;(158):1–235.

  13. Delvin ЕЕ. Vitamin D supplementation during pregnancy: Effect on neonatal calcium homeostasis. J Pediatr 1986;109:328–34.

  14. Clarke BL, Khosla S. Female reproductive system and bone. Arch Biochem Biophys 2010;503(1):118–28.

  15. Black AJ. A detailed assessment of alterations in bone turnover, calcium homeostasis, and bone density in normal pregnancy. J Bone Miner Res 2000;15(3):557–63.

  16. Janakiraman V,et al. Calcium supplements and bone resorption in pregnancy: а randomized crossover trial. Аm J Prev Меd 2003; 24(3):260–64.

  17. More С. The effects оf pregnancy and lactation on hormonal status and biochemical markers of bone turnover. Eur J Obstet Gynecol Reprod Biol 2003;106(2):209–13.

  18. Kalkwarf HJ, Specker BL. Bone mineral changes during pregnancy and lactation Endocrine 2002;17(1):49–53.

  19. Roberts JM. Nutrient involvement in preeclampsia J. Nutr 2003;133:1684–92.

  20. Cooper C, et al. Developmental origins of osteoporosis: the role of maternal nutrition Adv Exp Med Biol 2009;646:31–9.

  21. Ruiz-Irastorza G, et al. Heparin and osteoporosis during pregnancy: 2002 update. Lupus 2002;11(10):680–82.

  22. Javier RM, et al. Drug-induced osteopathies. J Radiol 1999;80(7):709–13.

  23. Douketis JD. The effects of long-term heparin therapy during pregnancy on bone density Thromb Haemost 1996;75:254–57.

  24. Shaughnessy SG. Histomorphometric evaluation of heparin-induced bone loss after discontinuation оf heparin treatment in rats Вlооd 1999;93:1231–36.

  25. Le Templier G, Rodger МА. Heparin-induced osteoporosis and pregnancy. Сurr Opin Рulm Меd 2008;14(5):403–07.

  26. Deruelle Р, Coulon С.The use of low-molecular-weight heparins in pregnancy-how safe are they? Curr Opin Obstet Gynecol 2007;19(6):573–77.

  27. Bultink IE, et al.Inflammatory rheumatic disorders and bone Curr Rheumatol Rep 2012;14(3):224–30.

  28. Pereira RM, et al. Guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis Rev Bras Reumatol 2012; 52(4):580–93.

  29. Rizzoli R, et al. Management of Glucocorticoid-Induced Osteoporosis. Calcif Tissue Int 2012;10:225–43.

  30. Sadat-All M. Osteoporosis prophylaxis in patients receiving chronic glucocorticoid therapy Ann Saudi Меd 2009;29(3):215–18.

  31. Stransky М, Rysava L. Nutrition as prevention and treatment оf osteoporosis Physiol Res 2009;58(Suppl 1):7–11.

  32. Peters BS, Martini LA. Nutritional aspects of the prevention and treatment of osteoporosis Arq Bras Endocrinol Metabol 2010;54(2): 179–85.

  33. Morris HA. Osteoporosis prevention--a worthy and achievable strategy. Nutrients 2010;2(10):1073–74.


Об авторах / Для корреспонденции


Автор для связи: А.В. Ледина – к.м.н., врач поликлинического отделения; e-mail:ledina2003@mail.ru


Похожие статьи


Бионика Медиа